Best of IDWeek 2022
Experts discuss a range of the most topical infectious disease research, presented at the recent IDWeek 2022 conference.
For the first time in 3 years, the IDWeek conference was held in-person.
Contagion was there, covering the latest developments in infectious disease research. Here's a roundup of some of our favorite interviews, featuring a range of the most significant topics covered at this year's conference.
Adjuvanted Novavax Booster Adapts to New Variants
What makes Novavax’s COVID-19 booster different? The adjuvanted vaccine “has kept recognizing variants that arise,” says Novavax executive director Germán Áñez, MD.
After Helen Boucher, MD, gave the Maxwell Finland presentation she spoke of the continuing issues as well as the encouraging aspects that have institutions working on the problem.
“It’s Potentially Game-Changing”: Hepatitis B Vaccination Protects People Living With HIV
A late-breaking IDWeek 2022 study found high seroprotection was achieved among people living with HIV after receiving 3 doses of a hepatitis B vaccine.
Building Momentum for the Pasteur Act
Amanda Jezek, senior vice president of public policy and government relations at IDSA, feels Congress is making significant progress toward antimicrobial resistance legislation.
Investigational RSV Vaccine for Seniors Demonstrates Efficacy and Safety
During a late breaking session at ID Week, an investigator presented data on the GSK vaccine that is in development.
